Neuromyelitis Optica Spectrum Disorder Consortium Act
Summary
Neuromyelitis Optica Spectrum Disorder Consortium Act This bill requires the National Institutes of Health to establish a national consortium to coordinate and support research on neuromyelitis optica spectrum disorder, including by awarding grants. This is a neurological disease that can cause blindness, paralysis, and premature death.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2021
Committee Review
Floor Vote
President
Introduced Jan 11, 2021
Last action Feb 2, 2021
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
2
Feb 2, 2021
Committee
Referred to the Subcommittee on Health.
lower
Jan 11, 2021
Committee
Referred to the House Committee on Energy and Commerce.
lower
Jan 11, 2021
Introduced
Introduced in House
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Barbara Lee
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 254
Scope: US
Hi! I can help you understand HR 254. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline